EP.13B.11 Clinical Outcomes of Continuous Immunotherapy Beyond Progression in Patients with Extensive-Stage Small Cell Lung Cancer
Back to course
Pdf Summary
Asset Subtitle
Jisheng Li
Meta Tag
Speaker Jisheng Li
Topic Small Cell Lung Cancer and Neuroendocrine Tumors
Keywords
continuous immunotherapy
extensive-stage small cell lung cancer
ES-SCLC
anti-PD-L1
anti-PD-1
immunochemotherapy
progression-free survival
anti-angiogenic therapy
immune checkpoint inhibitors
second-line treatment
Powered By